What is the ACTU stock price prediction for next 2 weeks?

According to our price prediction algorithm,Actuate Therapeutics Inc (ACTU) price will be around $5.24 in the next 2 weeks. This means it will decrease by -13.023255813953485 from the last closing price. This prediction may vary from other time period filters for ACTU stock.

What can be the highest Possible price of ACTU stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, ACTU can achieve the highest price of $5.58 which is -7.27528685769309 lower than last closing price. This prediction may vary from other time period filters for ACTU stock.

What can be the lowest Possible price of ACTU stock in next 2 weeks?

As per the forecast and algorithmic analysis, ACTU stock price can be as low as $4.91 which is -18.479963268756958 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for ACTU stock.

Will ACTU stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that ACTU stock will lose-13.023255813953485 in the next 2 weeks. This prediction may vary from other time period filters for ACTU stock.

What is ACTU stock last closing price?

Last closing price of ACTU stock was $6.12.

What is ACTU stock price prediction?

ACTU stock price prediction means predicting the future closing prices of ACTU stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of ACTU stock in a certain time period.

How we predict ACTU stock future prices?

If you are searching for ACTU stock forecast, analysis or price prediction, then you might be wondering what Actuate Therapeutics Inc (ACTU) will do in the future. Our ACTU price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This ACTU price prediction will likely answer most of your questions.

How frequent we update ACTU stock predictions?

We are updating the forecasts for the ACTU stock on daily basis.

Is using ML forecasting for ACTU stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for ACTU stock same for all the time periods?

No, the prediction for ACTU stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Actuate Therapeutics Inc Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$6.12-10.79%Since 2 Weeks

Predicted Price$5.24-13.02%For 2 Weeks

Upper Predicted Price$5.58-7.28%For 2 Weeks

Lower Predicted Price$4.91-18.48%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of ACTU will decline by -13.02% over the next 2 Weeks and hit $5.24 by Tuesday, January 13, 2026. In that time frame, ACTU's share price is expected to range between $4.91 and $5.58.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 13, 2026	4.91	5.24	5.58
Jan 12, 2026	4.93	5.27	5.61
Jan 9, 2026	5.35	5.67	5.99
Jan 8, 2026	5.20	5.52	5.84
Jan 7, 2026	5.35	5.65	5.96
Jan 6, 2026	5.28	5.58	5.90
Jan 5, 2026	5.30	5.61	5.92
Jan 2, 2026	5.72	6.02	6.33
Jan 1, 2026	5.57	5.86	6.18
Dec 31, 2025	5.70	5.99	6.32

ACTU shares rose +1.66% in Wednesday, December 31, 2025's trading session, rising from a previous close of $6.02 to move at $6.12. The stock demonstrated notable intraday movement (see ACTU's key stats for a full breakdown), fluctuating between $5.75 and $6.26, a +8.87% trading range. While recent weeks have seen some volatility, ACTU has managed to secure a -12.07% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 56.32K shares changing hands, 885 fewer than the previous session. This amounted to $344.67K in total market activity.

Will ACTU Continue Its Downward Trend?

According to analyst ratings and projections for ACTU, Actuate Therapeutics Inc shares are anticipated to decrease by -9.64%, potentially reaching $5.58 per share by January 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for ACTU. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the ACTU stock forecast, now is not the best time to buy ACTU stock because its current trading price is +16.88% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ACTU covering social and institutional perspectives.

ACTU Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into ACTU's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 33.53% to 41.24%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 45.90%, suggests a neutral medium-term outlook. Meanwhile, the 100-day RSI, at 52.63%, maintains a neutral outlook for the long term. Insights into ACTU's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Actuate Therapeutics Inc Monthly Forecast 2026

January 2026

According to our latest forecast models, Actuate Therapeutics Inc (ACTU) is positioned to show a strong performance in January 2026. The price is predicted to move between $16.05 and $21.39, settling at an average of $19.02. This could translate to a +210.78% gain.

February 2026

Based on current market signals, Actuate Therapeutics Inc is projected to trend february 2026. We forecast a trading range from $10.73 to $17.12, with a likely average price of $13.12. Investors could expect a potential return of +114.38%.

March 2026

Our predictive algorithms indicate Actuate Therapeutics Inc stock may see a shift in March 2026. The expected range spans $10.41–$15.48, with an average target of $12.73. This represents a positive outlook and a possible gain of +108.01%.

April 2026

Analyzing established trends, Actuate Therapeutics Inc looks set to move in April 2026. Projections place the stock between $11.18 and $15.08, averaging around $12.99. This suggests a +112.25% gain from current levels.

May 2026

Market indicators suggest Actuate Therapeutics Inc could experience notable changes during May 2026. Prices could fluctuate within $11.70 to $16.69, with a midpoint forecast of $14.40. The stock might deliver a +135.29% gain.

June 2026

Forecasting for June 2026, models estimate that Actuate Therapeutics Inc may undergo key fluctuations. If trends hold, the stock might trade between $9.75 and $12.19, averaging $10.97. This signals a positive trajectory with potential returns around +79.25%.

July 2026

According to our latest forecast models, Actuate Therapeutics Inc (ACTU) is positioned to show a strong performance in July 2026. The price is predicted to move between $6.39 and $12.52, settling at an average of $9.02. This could translate to a +47.39% gain.

August 2026

Based on current market signals, Actuate Therapeutics Inc is projected to trend august 2026. We forecast a trading range from $9.86 to $13.00, with a likely average price of $11.20. Investors could expect a potential return of +83.01%.

September 2026

Our predictive algorithms indicate Actuate Therapeutics Inc stock may see a shift in September 2026. The expected range spans $6.52–$12.57, with an average target of $9.54. This represents a positive outlook and a possible gain of +55.88%.

October 2026

Analyzing established trends, Actuate Therapeutics Inc looks set to move in October 2026. Projections place the stock between $6.09 and $10.45, averaging around $8.47. This suggests a +38.40% gain from current levels.

November 2026

Market indicators suggest Actuate Therapeutics Inc could experience notable changes during November 2026. Prices could fluctuate within $5.16 to $9.31, with a midpoint forecast of $7.28. The stock might deliver a +18.95% gain.

December 2026

Forecasting for December 2026, models estimate that Actuate Therapeutics Inc may undergo key fluctuations. If trends hold, the stock might trade between $7.11 and $8.75, averaging $8.04. This signals a positive trajectory with potential returns around +31.37%.

ACTU's history of dividends and stock splits also plays a role in long-term investor confidence.